EpCAM has a dynamic expression among CTCs of different origins and at different cancer stages [41]; it becomes highly downregulated when CTCs disseminate from primary sites and undergo epithelial-to-mesenchymal transmission (EMT) to acquire a more aggressive phenotype and seed for metastasis. This evidence concerns the gene EPCAM and cancer.